May 31, 2016
We have benefitted from a good performance in all aspects of the business in 2015, in particular biomarker services where there has been strong customer adoption of SysQuant® and TMTcalibrator™ with the focus on Precision Medicine. Considerable scientific progress has been made over the period, particularly in Alzheimer’s disease (Ad) across a number of different areas and these have formed the backcloth to the prominent releases and presentations that we have made at major Ad meetings in the USA and Europe.